Why the study?
Do beta-blockers provide clinical benefits in patients with heart failure?
Do beta-blockers provide clinical benefits in patients with heart failure?
This review summarizes the theoretical and clinical evidence supporting the efficacy of beta-blocker therapy in the treatment of heart failure.
Answers are grounded in this paper and cite their sources.
Supports beta-blocker use in HF; confirms mechanisms from prior trials but leaves open optimal application in contemporary cohorts.
Our understanding of factors contributing to the progression of heart failure has advanced dramatically over the past 2 decades. We have also gained considerable insight into the pharmacology of beta-adrenergic receptor blockers (beta-blockers). Based on this knowledge, we can now appreciate the potential of these drugs for the treatment of heart failure. Several beta-blockers have been shown to be clinically effective in the treatment of heart failure. Critical evaluation of the evidence from basic research studies, as well as clinical trials in patients with heart failure, helps to delineate the theoretical and clinical benefits of beta-blockers.
No takes yet. Share an insight, caveat, or question.
Sidney Goldstein (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: